Programmed cell death ligand 1 expression in aggressive pediatric non-Hodgkin lymphomas: frequency, genetic mechanisms, and clinical significance

Programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) are immunomodulatory molecules over-expressed in lymphomas and are promising immunotherapy targets for hematologic malignancies. However, studies of PD-1/PD-L1 overexpression and their clinical significance in aggressive pedia...

Descripción completa

Detalles Bibliográficos
Autores principales: Fisher, Kevin E., Ferguson, Lizmery S., Coffey, Amy M., Merritt, Brian Y., Curry, Jonathan L., Marcogliese, Andrea N., Major, Angela M., Kamdar, Kala Y., Lopez-Terrada, Dolores H., Curry, Choladda V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Article - Non-Hodgkin Lymphoma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335100/
https://www.ncbi.nlm.nih.gov/pubmed/35081690
http://dx.doi.org/10.3324/haematol.2021.280342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335100/
https://www.ncbi.nlm.nih.gov/pubmed/35081690
http://dx.doi.org/10.3324/haematol.2021.280342

Ejemplares similares